Ivercoast 12 Tablet contains Ivermectin 12 mg, an antiparasitic agent widely used for the treatment of various parasitic infections. Ivermectin acts by binding selectively and with high affinity to glutamate-gated chloride ion channels found in invertebrate nerve and muscle cells, leading to increased permeability to chloride ions, hyperpolarization, paralysis, and death of the parasite. This medication is indicated for the treatment of strongyloidiasis, onchocerciasis, and other parasitic infestations such as scabies and lice. Ivercoast 12 is administered orally, with dosage and duration determined by the type and severity of the infection, as well as patient weight and clinical response. It is generally well tolerated; however, adverse effects may include dizziness, nausea, diarrhea, and mild skin reactions. Caution is advised in patients with impaired liver function or those who are pregnant or breastfeeding. Ivermectin should not be used concurrently with other neurotoxic drugs without medical supervision. Prior to initiating therapy, a thorough clinical evaluation and confirmation of parasitic infection are recommended. Ivercoast 12 Tablet should be stored in a cool, dry place, away from direct sunlight, and kept out of reach of children. Always use under the guidance of a qualified healthcare professional.